Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 1, 2003, Pages 216-223

  Fischbein, Michael P ^a   Yun, James ^a   Laks, Hillel ^a   Irie, Yoshihito ^a   Oslund Pinderski, Laura ^a   Fishbein, Michael C ^a   Bonavida, Benjamin ^a   Ardehali, Abbas ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL INFILTRATION; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MORPHOMETRICS; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; STAINING; TRANSGENIC ANIMAL; VASCULAR DISEASE; WILD TYPE;

EID: 0041341981     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00026-6     Document Type: Article

References (29)

1. Fischbein MP, Yun J, Laks H, Irie Y, Fishbein MC, Espejo M, et al. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model. Transplantation. 2001;71:1146-53.
2. Fischbein MP, Ardehali A, Yun J, Schoenberger S, Laks L, Irie Y, et al. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol. 2000;165:7316-22.
3. Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TA, et al. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev. 1991;123:209-29.
4. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th I cells. J Immunol. 1991;146:3444-51.
5. Qin L, Chavin KD, Ding Y, Tahara H, Favaro JP, Woodward JE, et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol. 1996;156:2316-23.
6. Qian S, Li W, Li Y, Fu F, Lu L, Fung JJ, et al. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation. 1996;62:1709-14.
7. Furukawa Y, Becker G, Stinn J, Shimizu K, Libby P, Mitchell RN. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol. 1999;155:1929-39.
8. Nagano H, Libby P, Taylor MK, Hasegawa S, Stinn JL, Becker G, et al. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol. 1998;152:1187-97.
9. Nagano H, Mitchell R, Taylor M, Hasegawa S, Tilney N, Libby P. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 1998;100:550-7.
10. Hagenbaugh A, Sharma S, Dubinett S, Wei SH, Aranda R, Cheroutre H, et al. Altered immune responses in interleukin 10 transgenic mice. J Exp Med. 1997;185:2101-10.
11. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 1973;16:343-50.
12. Armstrong AT, Strauch AR, Starling RC, Sedmak DD, Drosz CG. Morphometric analysis of neointimal formation in murine cardiac grafts. Transplantation. 1997;63:941-7.
13. Fischbein MP, Yun J, Laks H, Irie Y, Fishbein MC, Bonavida B, Ardehali A. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg. 2002;123:803-9.
14. Chang CH, Furue M, Tamaki K. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur J Immunol. 1994;24:2889-95.
15. Raisanen-Sokolowski A, Glysing-Jensen T, Koglin J, Russell ME. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am J Pathol. 1998;152:359-65.
16. Raisanen-Sokolowski A, Mottram PL, Glysing-Jensen T, Satoskar A, Russell ME. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. J Clin Invest. 1997;100:2449-56.
17. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation. 1994;57:1367-71.
18. Li W, Fu F, Lu L, Narula SK, Fung JJ, Thomson AW, Qian S. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999;68:1402-9.
19. Yun J, Fischbein MP, Laks H, Fishbein MC, Espejo ML, Ebrahimi K, et al. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy. Transplantation. 2000;69:2515-24.
20. Yun JJ, Fischbein MP, Whiting D, Irie Y, Fishbein MC, Burdick MD, Belperio J, Strieter RM, Laks H, Berliner JA, Ardehali A. The role of MIG/CXCL9 in cardiac allograft vasculopathy. Am J Pathol. 2002;161:1307-13.
21. Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, Farber J, et al. Modulation of chemokine production and inflammatory responses in interferon-gamma and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol. 2001;158:1433-40.
22. Moore KW, de Waal Malefty R, Coffman RL, O'Garra AO. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
23. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403(6766):207-11.
24. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1993;158:670-89.
25. Rosa F, Fellous M. The effect of gamma-interferon on MHC antigens. Immunol Today. 1984;5:261-8.
26. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russel PS. Wide spread and selective induction of major histocompatibility complex-determined antigens in vivo by γ interferon. J Exp Med. 1985;162:1645-64.
27. Russell ME, Wallace AF, Hancock WW, Sayegh MH, Adams DH, Sibuga NE, et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 1995;59:572-8.
28. Mostafa Mtairag E, Chollet-Martin S, Oudghiri M, Laquay N, Jacob MP, Michel JB, et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TMP-1 secretion. Cardiovasc Res. 2001;49:882-90.
29. O'Farrell AM, Parry DA, Zindy F, Roussel MF, Lees E, Moore KW, et al. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation. J Immunol. 2000;164:4607-15.